Dr. Koyfman on the Evolution of Reirradiation Treatment in Head and Neck Cancer

Video

In Partnership With:

Shlomo Koyfman, MD, associate staff, Radiation Oncology, Cleveland Clinic, discusses recent advancements in reirradiation treatment for patients with head and neck cancer.

Shlomo Koyfman, MD, associate staff, Radiation Oncology, Cleveland Clinic, discusses recent advancements in reirradiation treatment for patients with head and neck cancer.

The reirradiation setting in head and neck cancer has been fortunate enough to see better imaging in the last decade or so, including better PET scanning and MRI scanning. A radiation oncologist treats what he sees, Koyfman explains. Thus, as the ability to see more, and to see more clearly, has gotten so much more advanced, radiation oncologists are able to be more selective about how they treat patients.

Koyfman says he tells his patients that the head and neck is a very "high real estate" area of the body, meaning that a lot of important parts are all located very close to one another. Radiation oncologists are now been able to apply this improved understanding of those structures to the reirradiation setting. Moreover, with more advanced technology and planning, these physicians can be much more careful about how they deposit doses of radiation, and critical structures can now be spared from unnecessary toxicities.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD